Atara Biotherapeutics

ATRA

Market cap $125M

17.27 USD

-0.32

1.82%

At close Updated Dec 26, 4:00 PM EST

Pre-market

After hours

17.50

+0.23

1.33%

1 day

-1.82%

5 days

-2.43%

1 month

16.22%

3 months

25.69%

6 months

117.23%

Year to date

21.96%

1 year

33.05%

5 years

-96.74%

10 years

-96.97%

About: Atara Biotherapeutics Inc operates in the United States healthcare sector. It focuses on developing transformative therapies for patients with serious diseases, including solid tumors, hematologic cancers, and autoimmune diseases. It operates and manages business as one operating and reportable segment which is the business of developing therapeutics. The company's product candidates comprise Tab-cel, ATA188, and ATA3219 (CAR T Platform).

Employees: 38

Healthcare Biotechnology